Mucopolysaccharidosis Ii

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-02
EMA Authorised: Elaprase (idursulfase) — Takeda Pharmaceuticals International AG Ireland Branch
Elaprase (idursulfase) has been authorised for worldwide or regional use in the EU for mucopolysaccharidosis II (Hunter syndrome).